AstraZeneca shares down as drug trial fails to meet target
- Posted on July 9, 2026
- By The Times
- 0 Views
- 1 min read
AstraZeneca shares down as drug trial fails to meet target
The company said Wainua ‘did not provide a statistically significant benefit’ for reducing cardiovascular deaths and recurring heart problems
